These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8365085)

  • 1. Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity, but has no effect on insulin sensitivity.
    Hosker JP; Kumar S; Gordon C; Bhatnagar D; France M; Boulton AJ
    Diabet Med; 1993 Jul; 10(6):509-13. PubMed ID: 8365085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
    Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.
    Mason TM; Goh T; Tchipashvili V; Sandhu H; Gupta N; Lewis GF; Giacca A
    Diabetes; 1999 Mar; 48(3):524-30. PubMed ID: 10078552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene).
    Clocquet AR; Egan JM; Stoffers DA; Muller DC; Wideman L; Chin GA; Clarke WL; Hanks JB; Habener JF; Elahi D
    Diabetes; 2000 Nov; 49(11):1856-64. PubMed ID: 11078452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three methods for the quantification of beta-cell function and insulin sensitivity.
    Nijpels G; van der Wal PS; Bouter LM; Heine RJ
    Diabetes Res Clin Pract; 1994 Dec; 26(3):189-95. PubMed ID: 7736899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effect of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Iversen S; Faber OK; Frøland A
    Scand J Clin Lab Invest; 1989 Jun; 49(4):337-43. PubMed ID: 2662383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetes.
    Hosker JP; Burnett MA; Matthews DR; Turner RC
    Metabolism; 1993 Sep; 42(9):1116-20. PubMed ID: 8412763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between beta-cell responsiveness and fasting plasma glucose in Caucasian subjects with newly presenting type 2 diabetes.
    Hovorka R; Albarrak A; Chassin L; Luzio SD; Playle R; Owens DR
    Diabet Med; 2001 Oct; 18(10):797-802. PubMed ID: 11678969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
    Carpentier A; Mittelman SD; Bergman RN; Giacca A; Lewis GF
    Diabetes; 2000 Mar; 49(3):399-408. PubMed ID: 10868961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.
    McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA
    Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
    Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
    Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.
    Wolffenbuttel BH; Menheere PP; Nijst L; Rondas-Colbers GJ; Sels JP; Nieuwenhuijzen Kruseman AC
    Neth J Med; 1992 Jun; 40(5-6):277-82. PubMed ID: 1436266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss.
    Camastra S; Manco M; Mari A; Baldi S; Gastaldelli A; Greco AV; Mingrone G; Ferrannini E
    Diabetes; 2005 Aug; 54(8):2382-9. PubMed ID: 16046305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men.
    Leung N; Sakaue T; Carpentier A; Uffelman K; Giacca A; Lewis GF
    Diabetologia; 2004 Feb; 47(2):204-13. PubMed ID: 14712348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitus.
    Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
    Diabet Med; 1994; 11(1):71-8. PubMed ID: 8181257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.
    Bak JF; Møller N; Schmitz O; Saaek A; Pedersen O
    Diabetologia; 1992 Aug; 35(8):777-84. PubMed ID: 1511806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
    Boden G; Chen X
    Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.